<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Insights — Reglo Medical Consulting</title>
    <link>https://medreglo.com/en/insights/</link>
    <description>Practical notes on FDA, EU MDR / IVDR and international medical device registration.</description>
    <language>en</language>
    <item>
      <title>FDA's QMSR FAQ: what manufacturers need to know</title>
      <link>https://medreglo.com/en/insights/fda-qmsr-faq/</link>
      <guid>https://medreglo.com/en/insights/fda-qmsr-faq/</guid>
      <pubDate>Sat, 07 Nov 2026 02:52:28 GMT</pubDate>
      <category>QMS</category>
      <description>QMSR has been in effect since 2 February 2026. FDA retired QSIT, introduced a new inspection process, and brought internal audit, supplier audit and management review reports into scope. The 13 FAQs, summarized, with our reading.</description>
    </item>
    <item>
      <title>Planning device changes in advance: FDA's 2024 draft guidance on PCCPs</title>
      <link>https://medreglo.com/en/insights/fda-pccp-draft-guidance/</link>
      <guid>https://medreglo.com/en/insights/fda-pccp-draft-guidance/</guid>
      <pubDate>Fri, 06 Nov 2026 02:22:21 GMT</pubDate>
      <category>FDA</category>
      <description>FDA's August 2024 draft guidance extends predetermined change control plans to all device types. What a PCCP can and cannot cover, and whether one is worth it for a PRP centrifuge.</description>
    </item>
    <item>
      <title>Does FDA accept clinical trial data from China?</title>
      <link>https://medreglo.com/en/insights/fda-china-clinical-data/</link>
      <guid>https://medreglo.com/en/insights/fda-china-clinical-data/</guid>
      <pubDate>Thu, 05 Nov 2026 03:04:36 GMT</pubDate>
      <category>FDA</category>
      <description>In its regulations, FDA has never refused clinical data from China. What decides acceptance is population representativeness, comparable standard of care and verifiable data, and Bayesian methods offer a quantifiable way to borrow data from outside the US.</description>
    </item>
    <item>
      <title>Regulatory update, November 2026: what changed in October</title>
      <link>https://medreglo.com/en/insights/2026-11-regulatory-update/</link>
      <guid>https://medreglo.com/en/insights/2026-11-regulatory-update/</guid>
      <pubDate>Tue, 03 Nov 2026 14:28:48 GMT</pubDate>
      <category>Monthly update</category>
      <description>China's new device GMP took effect on 1 November; EUDAMED registration for devices already on the EU market closes on 28 November; the US, EU and Australia keep refining their rules for medical device software.</description>
    </item>
    <item>
      <title>Regulatory update, October 2026: what changed in September</title>
      <link>https://medreglo.com/en/insights/2026-10-regulatory-update/</link>
      <guid>https://medreglo.com/en/insights/2026-10-regulatory-update/</guid>
      <pubDate>Tue, 03 Nov 2026 13:49:38 GMT</pubDate>
      <category>Monthly update</category>
      <description>FDA confirms radiology AI software still needs a 510(k); the FY2027 FDA annual registration window opened on 1 October; EUDAMED registration for devices already on the EU market closes on 28 November.</description>
    </item>
  </channel>
</rss>